D-0843-2020 Class III Terminated

Recalled by Par Pharmaceutical Inc. — Chestnut Ridge, NY

FDA drug recall D-0843-2020 was initiated by Par Pharmaceutical Inc. on Feb 10, 2020 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022. The recall status is terminated (terminated Nov 17, 2020). Affected quantity: 9,936 cartons.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Feb 10, 2020
Termination Date
Nov 17, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,936 cartons

Product description

Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Services Limited, Craigavon, BT63 5UA, UK; Manufactured for: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 0603-3718-34.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.

Distribution pattern

Nationwide in the USA

Code information

Lot Number: 9698818; labeled expiration AUG 2022; actual expiration APR 2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0843-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0843-2020. Report a data issue: hello@regdatalab.com.